Kalaris Therapeutics, Inc.
KLRS
$4.16
$0.081.84%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/5/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
6/3/2026
-
Tickeron - Stocks
Analysts Offer Insights on Healthcare Companies: Kalaris Therapeutics (KLRS) and Nuvation Bio (NUVB)
6/1/2026
-
TipRanks Financial Blog
5/29/2026
-
Tickeron - Stocks
5/27/2026
-
Tickeron - Stocks
5/27/2026
-
Tickeron - Stocks
5/25/2026
-
TipRanks Financial Blog
5/24/2026
-
Tickeron - Stocks
5/22/2026
-
Tickeron - Stocks
5/22/2026
-
Tickeron - Stocks
5/21/2026
-
Tickeron - Stocks
5/20/2026
-
Tickeron - Stocks
5/20/2026
-
Tickeron - Stocks
5/20/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/14/2026
-
The Cerbat Gem
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
Seeking Alpha - Healthcare
5/12/2026
-
SeekingAlpha.com: All News
5/12/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650-249-2727
Address
400 Connell Drive
Suite 5500 - Berkeley Heights
Berkeley Heights, NJ 07922
Suite 5500 - Berkeley Heights
Berkeley Heights, NJ 07922
Country
Year Founded
Business Description
Sector
Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a...
more